1Davin JC, Weening JJ.Diagnosis of Henoch-Schonlein purpura: renal or skin biopsy?Pediatr Nephrol, 2003, 18( 12): 1201-1203.
2Ronkainen J, Ala-Houhala M, Huttunen NP, et al.Outcome of Henoch-Schonlein nephritis with nephriticrange proteinuria.Clin Nephrol, 2003, 60( 2): 80-84.
5Kawasaki Y, Suzuki J, Sakai N, et al.Clinical and pathological features of children with Henoch-Schonlein purpura nephritis: risk factors associated with poor prognosis.Clin Nephrol, 2003, 60( 3): 153-160.
1Ronkainen J,Ala-Houhala M,Huttunen NP,et al. Outcome of Henoch- Schonlein nephritis with nephrotic-range proteinuria.Clin Nephrol, 2003,60(2): 80-84.
2Tarshish P,Bernstein J,Edelmann CM. Henoch-Schonlein purpura nephritis:course of disease and efficacy of cyclophosphamide. Pediatr Nephrol, 2004,19 ( 1 ): 51-56.
3Ronkainen J,Nuutinen M,Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura:a retrospective cohort study. Lancet,2002,360(9334) :666-670.
4Kawasaki Y,Suzuki J,Sakai N,et al. Clinical and pathological features of children with Henoch- Schonlein purpura nephritis:risk factors associated with poor prognosis. Clin Nephrol, 2003,60(3): 153-160.
5Davin JC ,Ten Berge IJ,Weening JJ. What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis ? Kidney Int, 2001,59 (3): 823-834.
7Haddad E,Moura IC,Arcos-Fajardo M,et al. Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schonlein nephritis:association between CD71 expression and IgA deposits. J Am Soc Nephrol,2003,14(2):327-337.
8Pabunruang W,Treepongkaruna S,Tangnararatchakit K, et al.Henoch- Schonlein purpura:clinical manifestations and longterm outcomes in Thai children. J Med Assoc Thai,2002,85(suppl 4) :S1213-S1218.
9Algoet C,Proesmans W. Renal biopsy 2-9 years after Henoch-Schonlein purpura. Pediatr Nephrol, 2003,18 (5) :471-473.
10Niaudet P,Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Henoch- Schonlein purpura nephritis. Pediatr Nephrol, 1998,12 (3): 238-243.